Company FutureChem Co.,Ltd

Equities

A220100

KR7220100002

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sector Diagnostic & Testing Substances

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-19 EDT			5-day change	1st Jan Change
14,220 ^KRW	+2.01%		+20.71%	+34.79%

2023	FutureChem Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2023	FutureChem Healthcare announced that it has received KRW 7.500000097 billion in funding from FutureChem Co.,Ltd	CI

FutureChem. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The Company manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The Company also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.

KRW in Million	2022	Weight	2023	Weight	Delta
Reagents and Radioactive Medicines 100.0 %	12,574	100.0 %	13,968	100.0 %	+11.09%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	12,574	100.0 %	13,968	100.0 %	+11.09%

Managers	Title	Age	Since
Dae-Yoon Ji CEO	Chief Executive Officer	69	-
Young-Il Yoo DFI	Director of Finance/CFO	50	16-12-31
Cheol Kim AUD	Comptroller/Controller/Auditor	57	17-03-12

Members of the board	Title	Age	Since
Chul-Soo Lee BRD	Director/Board Member	64	-
Jun-Gi Jung BRD	Director/Board Member	71	19-03-23
Dae-Yoon Ji CEO	Chief Executive Officer	69	-
Hee-Sub Gil BRD	Director/Board Member	52	01-07-31
Young-Il Yoo DFI	Director of Finance/CFO	50	16-12-31
Ma Hoon BRD	Director/Board Member	49	19-03-23
Kuk-Cheol Jeong BRD	Director/Board Member	46	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	22,102,155	19,088,497 ( 86.36 %)	5,227 ( 0.0236 %)	86.36 %

Name	Equities	%	Valuation
Dae-Yoon Ji 6.073 %	1,342,290	6.073 %	13 M ₩
Young-Ja Park 6.039 %	1,334,821	6.039 %	13 M ₩
Hee-Sub Gil 0.5046 %	111,517	0.5046 %	1 M ₩
Hyo-jin Ji 0.3321 %	73,400	0.3321 %	699 958 ₩
Hyung-mim Ji 0.3071 %	67,884	0.3071 %	647 356 ₩
Young-Il Yoo 0.2478 %	54,759	0.2478 %	522 193 ₩
Jun-Gi Jung 0.0979 %	21,637	0.0979 %	206 335 ₩
FUTURECHEM CO.,LTD 0.0236 %	5,227	0.0236 %	49 846 ₩
DFA Australia Ltd. 0.0109 %	2,404	0.0109 %	22 925 ₩
Futurechem Co., Ltd. ESOA 0.008248 %	1,823	0.008248 %	17 385 ₩

Name	Equities	%	Valuation
FUTURECHEM CO.,LTD 0.02%	5,227	0.02%	49,846 $

FutureChem Co., Ltd.

21 Yeonmujang3-gil Seongdong-gu

04782, Seoul

http://www.futurechem.co.kr

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
FUTURECHEM CO.,LTD	+34.79%	231M
BIOMÉRIEUX	-6.11%	12.23B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-3.86%	8.17B
LANTHEUS HOLDINGS, INC.	+33.66%	5.74B
AUTOBIO DIAGNOSTICS CO., LTD.	-7.35%	4.24B
10X GENOMICS, INC.	-55.63%	2.97B
ANDON HEALTH CO., LTD.	+13.62%	2.73B
VITROLIFE AB	-3.70%	2.38B
MYRIAD GENETICS, INC.	+30.67%	2.26B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-4.31%	1.87B

Diagnostic & Testing Substances